Anacetrapib
- Generic Name
- Anacetrapib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C30H25F10NO3
- CAS Number
- 875446-37-0
- Unique Ingredient Identifier
- P7T269PR6S
- Indication
用于冠状动脉疾病（CHD）和动脉粥样硬化。
- Associated Conditions
- -
- Associated Therapies
- -
A Galactose-Based Monosaccharide Gal-3 Inhibitor from BMS with Potential in Targeting Fibrotic Diseases
Merck's MK-8262, a potential best-in-class CETP inhibitor, was discontinued as a backup due to the success of anacetrapib in Phase III. Reviewer Kim Huard praised it as a great example of handling a lipophilic binding site.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath